Introduction {#s1}
============

To the memory of Louis J. De Felice. A great scientist, an inspiring mentor, and, simply, a great friend. "...never forget the physics behind it!"

Voltage-gated, potassium-selective (K~V~) channels from the K~V~7 family are commonly found in the cardiovascular, gastrointestinal, and nervous systems. They are the main molecular entities responsible for the so-called M-currents which are voltage-dependent K^+^-currents suppressed by the activity of Gq protein-coupled receptors (GqPCRs) ([@B10]; [@B86]; [@B30]; [@B15]). K~V~7 channels can display measurable activity at voltages as negative as −60 mV, making them into critical contributors to the maintenance of the resting membrane potential ([@B10]; [@B86]; [@B30]; [@B15]; [@B39]; [@B62]; [@B45]; [@B46]). In the nervous system, K~V~7 channels are critically involved in controlling excitability in neurons. Indeed, mutations that impair the normal functioning of K~V~7 channels cause neurological disorders such as Benign Familial Neonatal Seizures ([@B13]; [@B61]; [@B17]; [@B92]), Early Onset Epileptic Encephalopathy ([@B87]; [@B88]; [@B45]; [@B46]; [@B1]), and Peripheral Nerve Hyperexcitability ([@B17]; [@B91]).

The role of K~V~7 channels in the control of excitability in electrically active cells have been long recognized. So has been the potential of these proteins as therapeutic targets for hyperexcitability disorders such as chronic pain, epilepsy, and cardiac arrhythmias ([@B10]; [@B86]; [@B30]; [@B15]; [@B39]; [@B62]; [@B45]; [@B46]). For instance, Retigabine, a first-in-class anticonvulsant, was recently used in the U.S. to treat epileptic disorders in adults ([@B57]; [@B89]). This drug is a K~V~7 agonist that facilitates the opening of all members of the K~V~7 family, except for K~V~7.1 ([@B42]; [@B59]; [@B90]). In the presence of Retigabine, the voltage-dependence for activation of K~V~7.2 and K~V~7.3 channels shifts toward more negative potentials, reaching up to a −40-mV shift at a concentration of 100 µM of this drug ([@B57]; [@B89]; [@B42]; [@B58]; [@B73]; [@B59]; [@B90]; [@B23]; [@B31]). This effect made Retigabine into a promising drug for the treatment of epilepsy and related disorders ([@B54]). In spite of the benefits offered by this agonist, Retigabine usage was limited in 2017 because it causes undesirable side effects in patients that outweighed its therapeutic prowess ([@B9]; [@B54]; [@B8]). Nonetheless, the use of Retigabine has highlighted the potential of targeting K~V~7 channels in the treatment of hyperexcitability disorders. Furthermore, Retigabine remains to be an important research tool and a model K~V~7 drug.

Two basic premises were considered when defining the deactivation of K~V~7.2/K~V~7.3 channels as the main focus of the present study. Those premises are: 1) K~V~7.2/K~V~7.3 channels activation is typically slower than the duration of a typical neuronal action potential (AP). 2) At the usual resting potential of a neuron, a fraction of these channels has been already opened. The first premise suggests that during a single neuronal AP, the increase in the number of activated K~V~7.2/K~V~7.3 channels is negligible ([@B16]). The second premise suggests that the control of excitability by M-currents is carried out by those K~V~7.2/K~V~7.3 channels that are already open in steady state at the resting potential ([@B16]). Combined, both ideas imply that the stability of the activated/open channel is critical for the physiological function of K~V~7 channels. Therefore, the present work focuses on studying channel deactivation as a proxy to understand open channel stabilization.

The signaling lipid phosphatidylinositol-4,5-bisphosphate (PI(4,5)P~2~) is essential for the activity of K~V~7 channels. PI(4,5)P~2~ is the most abundant phosphoinositide in the plasma membrane, constituting about 1% of the total lipids in its inner leaflet ([@B19]). An increase in the concentration of either PI(4,5)P~2~ or analogous molecules in the intracellular side boosts the open probability of the heteromeric K~V~7.2/K~V~7.3 channel ([@B38]; [@B74]). This implies that decreasing the concentration of this phosphoinositide reduces activity by likely reducing the stability of the open channel as shown by single channels recordings of M-currents ([@B44]). Following this idea, a set of experiments were performed in this study to assess the effect of depleting the plasma membrane of PI(4,5)P~2~ on the overall kinetics of deactivation of K~V~7.2/K~V~7.3 channels.

One common strategy to experimentally deplete PI(4,5)P~2~ in cells is to co-express a voltage-sensitive phosphatase ([@B48]; [@B53]). These membrane proteins are phosphoinositide-specific phosphatases with voltage-dependent activity that can efficiently dephosphorylate the inositol head group of these lipids, effectively depleting the membrane of PI(4,5)P~2~ ([@B81]; [@B53]). In fact, the strong action of VSPs such as Ci-VSP, Dr-VSP, and others can degrade PI(4,5)P~2~ into PI(4)P within a few hundreds of milliseconds, reversibly abolishing K~V~7 currents ([@B65]; [@B99]; [@B80]). This ability of shutting down channel activity when employing traditional VSPs would make unfeasible to study the role of PI(4,5)P~2~ on deactivation following prolonged depolarizations because there will be no currents left to study. To circumvent this issue, the chimeric VSP Ci-VS-TPIP (or hVSP1) was used instead of traditional VSPs such as Dr-VSP. Ci-VS-TPIP is a chimeric VSP that contains the voltage-sensor of Ci-VSP and the catalytic domain of the human VSP known as TPIP ([@B25]) (a.k.a. Hs-VSP1 ([@B25]; [@B82]; [@B53])). It has been already shown that the activation of Ci-VS-TPIP can effectively decrease K~V~7.2/K~V~7.3 channel activity without fully abolishing K^+^-currents ([@B25]). This property made Ci-VS-TPIP into the ideal VSP for this study.

Retigabine and Flupirtine are able to mitigate the effect of PI(4,5)P~2~ depletion on the activity of K~V~7.2/K~V~7.3 and K~V~7.3 channels ([@B39]; [@B32]), while increases in PI(4,5)P~2~ levels reduced Retigabine-induced K~V~7 currents activation ([@B63]). Although the mechanism underlying this action remains unclear, single channel recordings show that Retigabine increases the lifetime of open state events of K~V~7.2/K~V~7.3 channels, while decreasing the dwelling-time of closed channel events ([@B73]). Further, the mean-open-time of the isolated pore of K~V~7.3 channel increases in the presence of Retigabine ([@B69]). Furthermore, the deactivation rate of both K~V~7.2/K~V~7.3 and K~V~7.3 channels decreases in the presence of Retigabine ([@B89]; [@B16]; [@B32]). These observations likely indicate that Retigabine increases the stability of the activated/open channel conformation. In addition, Retigabine can also decrease the deactivation rate of channels that are open at typical neuronal resting potential ([@B16]). This indicates that Retigabine acts independently of how channels are being opened.

The slowdown of the deactivation rate of the heteromeric K~V~7.2/K~V~7.3 channel can be attributed to conformational rearrangements in the protein that occur following activation. This channel seems to display at least two modes of activity. One mode is observed immediately after activation, and a second mode adopted following prolonged activation ([@B16]). Deactivation from this second mode is slower than from the first mode. One intriguing observation is that the effectiveness of Retigabine in decreasing the deactivation rate of K~V~7.2/K~V~7.3 channels is higher as the activation is prolonged ([@B16]). This is consistent with the idea that the distinct deactivation rates correspond to distinct conformation of the protein such that the action of Retigabine changes as a function of the deactivation rate. This indicates that the distinct rates of deactivation in K~V~7.2/K~V~7.3 channels can be modes of activity that have distinct kinetic and pharmacological properties.

It has been well established that GqPCR regulation of M-current is mainly mediated by degradation of PI(4,5)P~2~ ([@B65]; [@B99]; [@B67]; [@B18]; [@B26]; [@B28]). Activation of GqPCR leads to the hydrolysis of PI(4,5)P~2~ by PLCβ into IP~3~ and DAG. Through this process, the concentration of PI(4,5)P~2~ in the plasma membrane is reduced, decreasing the activity of K~V~7 channels ([@B65]; [@B99]; [@B18]; [@B66]; [@B68]). The action of PI(4,5)P~2~ seems to promote K~V~7 channel opening by boosting open probability (P~O~) ([@B18]; [@B74]). Consistently, the activity of K~V~7.2-4 channels increases as a function of diC8-PIP~2~ concentration ([@B18]); diC8-PIP~2~ is a short-aliphatic chain analog of PI(4,5)P~2~. Single channel recordings seemingly show that this increase in P~O~ emerges from both reducing the duration of closed events and increasing the duration of the open events ([@B18]). On the other hand, decreasing the concentration of PI(4,5)P~2~ decreases that deactivation time constant of K~V~7.2 channels ([@B14]). These observations suggest that the presence of PI(4,5)P~2~ is critically needed for the stabilization of open channel conformations. Yet, decreasing the mean open event lifetime does not necessarily translate into faster deactivation.

It is important to define the following: Referring to an activated/open channel means channels sojourning between conducting (open) and non-conducting (closed) states, resulting in *open* and *closed* events. In other words, the open probability is higher than zero. While when referring to an open event, it is simply a single channel conducting ions (open event). Considering this, if 1) PI(4,5)P~2~ stabilizes the activated/open K~V~7.2/K~V~7.3 channel and 2) Retigabine is more effective in decreasing the deactivation rate after prolonged activation, it can be expected that depletion of PI(4,5)P~2~ will hamper the stabilizing action of Retigabine on activated/open K~V~7.2/K~V~7.3 channels. To test this hypothesis, the present study analyzed how PI(4,5)P~2~ depletion affected the deactivation of K~V~7.2/K~v~7.3 channels expressed in *Xenopus* oocytes. To decrease the PI(4,5)P~2~ content in these cells, two approaches were employed: One, the co-expression of channels and the chimeric voltage-sensitive phosphatase Ci-VS-TPIP. Two, treatment of oocytes with the phosphoinositide-kinase inhibitor Wortmannin. Here, it is shown that either approach led to increasing the deactivation rate of K~V~7.2/K~V~7.3 channels. Furthermore, it was found that these treatments reduced the effect of Retigabine on the deactivation kinetics. These observations indicated that decreasing PI(4,5)P~2~ concentration had a higher impact on channel deactivation following prolonged activation. These results suggested that K~V~7.2/K~V~7.3 channels in their second mode of activity are more susceptible to PI(4,5)P~2~ depletion than those in the first mode of activity. Extrapolating these results led to postulate that the modal behavior in K~V~7.2/K~V~7.3 channels is likely the physiological target for GqPCR-mediated regulation.

Materials and Methods {#s2}
=====================

Preparation of Oocytes and RNA Injections {#s2_1}
-----------------------------------------

RNA preparation, *Xenopus laevis* oocyte isolation, preparation, and RNA injection were performed using published methods ([@B79]; [@B80]; [@B16]). Animal protocols were approved by the Institutional Animal Care and Use Committees at University of the Pacific and conform to the requirements in the Guide for the Care and Use of Laboratory Animals from the National Academy of Sciences. Ovarian lobules were surgically harvested from frogs purchased from Xenopus 1 (Dexter, MI, U.S.A.). Oocytes were maintained at 16--17°C in a solution of (in mM): 100 NaCl, 1 KCl, 2 CaCl~2~, 1 MgCl~2~ or MgSO~3~, 10 HEPES, 2 Pyruvic acid, pH 7.5, and 20--50 mg/L of gentamycin. Results from many batches of oocytes were combined.

Electrophysiology {#s2_2}
-----------------

Oocytes were injected with 2 ng of each *in vitro*--transcribed cRNA encoding for the human K~V~7.2 and K~V~7.3 channels and 0.4 ng of the chimeric construct Ci-VS-TPIP. Injected oocytes were incubated at 16--17°C for 2--4 days before recordings. The incubation solution was titrated to pH 7.5 with NaOH and contained (in mM): 99 NaCl, 1 KCl, 10 HEPES, 1 MgCl~2~, 1.8 CaCl~2~, 1 MgCl~2~, 2 Pyruvic acid, and 20--50 mg/L of Gentamycin.

Potassium currents were recorded using the *Xenopus* oocyte Cut-Open Voltage-Clamp (COVC) technique with a CA-1 amplifier (Dagan Corporation, Minneapolis, MN, U.S.A.). The external recording solution contained (in mM): 12 KOH, 88 N-methyl-D-glucamine, 100 Methanesulfonic acid, 10 HEPES, 1 Mg(OH)~2~, and 2 Ca(OH)~2~. The intracellular solution contained (in mM): 100 KOH, 100 Methanesulfonic acid, 10 HEPES, 1 Mg(OH)~2~, and 2 EGTA. Both solutions were titrated to pH 7.4 with Methanesulfonic acid. Retigabine (Alomone Labs, Jerusalem, Israel) was dissolved at 50 mM in DMSO. Wortmannin (Tocris Biosicences, Bristol, U.K.) was dissolved at 20 mM in DMSO. The external solution used for control was added with 0.002%--0.02% (v/v) of DMSO to account for potential effect of the solvent on the activity of the channels. Borosilicate glass electrodes (resistance = 0.2--2.0 MΩ) were filled with a solution containing (in mM) 1,000 KCl, 10 HEPES and 10 EGTA, at pH 7.4 titrated with KOH.

As previously described, voltage control and current acquisition was performed using a USB-6251 multi-function acquisition board (National Instruments, Austin, TX, U.S.A.) controlled by an in-house program coded in LabVIEW (National Instruments, Austin, TX, U.S.A.) (details available upon request). Current signals were filtered at 100 kHz, oversampled at 500 kHz--2 MHz, and stored at 5--25 kHz for offline analysis. Data were analyzed using a custom Java-based software (details available upon request) and Origin 2019 (OriginLab, Northampton, Massachusetts, U.S.A.).

Exponential Fits and Weighted Average Time Constant {#s2_3}
---------------------------------------------------

As described in previous studies ([@B89]; [@B35]; [@B83]; [@B16]), the following two-exponential function was fitted to the deactivating currents:
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Where, *A*~1~ and *A*~2~ are the current amplitude associated with each component and τ~1~ and τ~2~ are the corresponding time constants. Fittings were done using Origin 2019 (OriginLab). When needed, the deactivation weighted average time constant (τ~DEACT~) was calculated as
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The fractional amplitude of the second exponential component was calculated as
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T-test were calculated for statistical analysis of the time constants.

It is important to highlight that the two-exponential equation was not derived from a comprehensive kinetic model describing the activity of K~V~7 channels. Instead, it was selected because it can tightly trace deactivating currents. Consequently, the parameters yielded from fitting the equation to such currents can only provide a temporal description of the deactivation process. Meaningful assignment of each individual parameter to any physical process underlying the activity of the channel under study is therefore very limited and even inadequate.

Molecular Biology {#s2_4}
-----------------

The constructs human KCNQ2 and KCNQ3 in the expression vector pTLN, encoding K~V~7.2 and K~V~7.3 channels, were linearized with MluI and HpaI (New England Biolabs, Ipswich, MA, U.S.A.), respectively. The linearized K~V~7-encoding cDNA was transcribed using a SP6 RNA polymerase kit (Ambion mMessage mMachine, Life Technologies, Carlsbad, CA, U.S.A.). The Ci-VS-TPIP construct in pBSTA was linearized with NotI and transcribed with a T7 RNA ARCA polymerase kit (New England Biolabs). The chimeric phosphatase Ci-VS-TPIP (also known as hVSP1~CiV~) was built by fusing the voltage-sensing domain of the *Ciona instestinalis* voltage-sensitive phosphatase Ci-VSP ([@B48]) and the catalytic domain of the human voltage-sensitive phosphatase known as TPIP or Hs-VSP1 ([@B85]). The catalytic selectivity of this construct has been previously characterized, showing that this enzyme decreases PI(4,5)P~2~ in the plasma membrane ([@B25]).

Results {#s3}
=======

Phosphatase Activity Increases the Deactivation Rate of the K~V~7.2/K~V~7.3 Channel {#s3_1}
-----------------------------------------------------------------------------------

K^+^-currents were recorded from *Xenopus laevis* oocytes injected with cRNA encoding the human K~V~7.2 and K~V~7.3 channels. From a holding potential (H.P.) set at −90 mV, K^+^-currents were activated by applying 1200-ms test pulses with amplitudes ranging between −100 mV and +60 mV ([**Figure 1**](#f1){ref-type="fig"}). Subsequently, K^+^-currents deactivated by applying a −105-mV pulses ([**Figure 1**](#f1){ref-type="fig"}, red arrow). A two-exponential function was fitted to the deactivating currents, yielding two time-constants, namely, τ~1~ and τ~2~. Using these values, weighted average deactivation time constants (τ~DEACT~) were calculated and plotted against the amplitudes of the activating pulse potential ([**Figure 1A**](#f1){ref-type="fig"}, insert). As previously reported ([@B16]), τ~DEACT~ increased as the amplitude of the activation pulse increased, suggesting that channels became harder-to-close as the activation was stronger. A similar profile was observed when co-expressing the chimeric phosphatase Ci-VS-TPIP ([**Figure 1B**](#f1){ref-type="fig"}). However, τ~DEACT~ were smaller at all activating potentials ([**Figure 1B**](#f1){ref-type="fig"}, insert). These observations indicated that the action of Ci-VS-TPIP increases the rate of deactivation of the heteromeric K~V~7.2/K~V~7.3 channels. This suggested that depleting the membrane of PI(4,5)P~2~ increases the deactivation rate of K~V~7.2/K~V~7.3 channels.

![K^+^-currents recorded form *Xenopus* oocytes expressing the heteromeric K~V~7.2/K~V~7.3 channel. **(A)** From a holding potential (H.P.) set at −90 mV, channel activity was probed by applying 1200-ms pulses from −100 mV to +60 mV followed by channels deactivation at −105 mV (red arrow). **(A), inset** The deactivation kinetics was assessed by fitting a two-exponential function to deactivating ("tail") currents (red arrow), calculating the weighted average time constant as shown in methods (τ~DEACT~), and plotting τ~DEACT~ as a function of the activating-pulse potential amplitude (V~ACT~). Example of a τ~DEACT~-V~ACT~ plot is showed that deactivation speed decreased as V~ACT~ was more positive. **(B)** Co-expressing the chimeric voltage-sensitive phosphatase Ci-VS-TPIP accelerated the deactivation of the K^+^-current (red arrow). (**B, inset**) τ~DEACT~-V~ACT~ plot showed that activation of Ci-VS-TPIP increased the speed of deactivation. **(C)** Voltage dependence of activation was assessed by plotting the amplitude of deactivating current (I~TAIL~) normalized by its maximum value (I~TAIL,MAX~). **(D)** Similar plot than on C. However, I~TAIL~ was normalized by the amplitude of the tail current recorded following an activating pulse to −10 mV (I~TAIL,−10mV~).](fphar-11-00895-g001){#f1}

To assess the effect of the phosphatase activity on activation, the normalized deactivating ("tail") current amplitudes were plotted against the corresponding activating pulse potentials ([**Figure 1C**](#f1){ref-type="fig"}). These I~TAIL~-V~PULSE~ plots showed that the voltage dependence seemed to be altered by the expression of Ci-VS-TPIP. However, the effect at more positive potentials is likely due to the phosphatase own voltage-dependence for its activity; Ci-VS-TPIP activity increases as the membrane potential is made more positive ([@B25]). Considering this, "tail" current amplitudes were normalized to match the curves at more negative side of the amplitude-voltage relationship at which the phosphatase activity is lower. To do so, tail current amplitudes were normalized with respect to the amplitude observed following a −10-mV activating pulse. The newly generated I~TAIL~-V~PULSE~ plots overlapped at potentials 0 mV and below ([**Figure 1D**](#f1){ref-type="fig"}), suggesting that the action of Ci-VS-TPIP had a low impact in the voltage-dependence for activation of K~V~7.2/K~V~7.3 channels.

Phosphatase Activity Hampers the Activation-Induced Decrease in the Deactivation Rate {#s3_2}
-------------------------------------------------------------------------------------

To further assess the effect of Ci-VS-TPIP on the deactivation kinetics of the heteromeric K~V~7.2/K~V~7.3 channel, deactivating K^+^-currents were recorded at −90 mV, following +40-mV pulses of increasing duration ([**Figures 2A, B**](#f2){ref-type="fig"}). As before, a two-exponential function was fitted to the deactivating currents and the yielded time-constants plotted against the duration of the activating pulse (t~PULSE~) ([**Figures 2C, D**](#f2){ref-type="fig"}). For the channels alone, both τ~1~ and τ~2~ increased as t~PULSE~ increased ([**Figures 2C, D**](#f2){ref-type="fig"}, black squares), indicating that channels became harder-to-close as they were activated for longer time. Noteworthy, the increase of both τ~1~ and τ~2~ seemed to ensue in two phases. The first phase occurred within the first 100--200 ms following activation ([**Figures 2G, H**](#f2){ref-type="fig"}, black squares) and the second phase slowly developed thereafter. Likewise, the relative contribution of second exponential component (fraction of τ~2~) decreased during the initial phase, remaining relative constant thereafter ([**Figures 2E, J**](#f2){ref-type="fig"}, black squares). From this analysis, it became evident that the overall tendency of the deactivation kinetics was to slow down as a function of t~PULSE~. An obvious pattern among τ~1~, τ~2~ and the fraction of τ~2~ that could clearly pinpoint any mechanistic underpinnings of this process was not identified. This was not surprising as the two-exponential function used was not derived from a comprehensive kinetic model for activity of this channel. Therefore, to facilitate the interpretation of the data, it was decided to merge these kinetic parameters into a single measure, so generating a τ~DEACT~-*vs*-t~PULSE~ plot ([**Figures 2F, J**](#f2){ref-type="fig"}). These new plots showed the same trend discussed above for τ~1~ and τ~2~ with τ~DEACT~ increasing with t~PULSE~ in two phases. These observations strongly suggest that the open channel became harder-to-close as remained open. These results were consistent with the idea that K~V~7.2/K~V~7.3 channels undergo a transition from the activated/open channel into a more stable conducting configuration.

![Co-expression of Ci-VS-TPIP accelerates the deactivation kinetic of K~V~7.2/K~V~7.3 channels. **(A)** K^+^-current recorded from *Xenopus* oocytes expressing K~V~7.2/K~V~7.3 channels were activated by applying +40-mV pulses of variable duration from a H.P. set at −90 mV. Deactivation was then driven at −90 mV (red arrow). **(B)** Equivalent recordings were performed from oocytes co-expressing Ci-VS-TPIP. In these recordings, the amplitude of K^+^-currents slowly decayed during activation. This was expected because the activating +40-mV pulse further activates Ci-VS-TPIP, decreasing the PI(4,5)P~2~ concentration in the membrane. **(C, D)** A two-exponential function was fitted to the deactivating currents and the resulting time constants for the first (τ~1~) and second (τ~2~) components of the function were plotted against the duration of the +40-mV activating pulse (t~PULSE~) in the absence (black open squares, *n* = 8) or presence of Ci-VS-TPIP (red open circles, *n* = 13). **(E)** Plot of the relative contribution of the second component of the two-exponential function (fraction of τ~2~) *versus* t~PULSE~ in the absence (black open squares, *n* = 8) or the presence of Ci-VS-TPIP (red open circles, *n* = 13). **(F)** Weighted average time constant (τ~DEACT~) plotted against t~PULSE~ in the absence (black open squares, *n* = 8) or the presence of Ci-VS-TPIP (red open circles, *n* = 13). **(G--J)** Semi-logarithmic version of the plot in **(C--F)**, detailing τ~DEACT~ for t~PULSE~ up to 1 s. the Arrows in panel **(C, D, F--H, J)** indicate the range of t~PULSE~ values at which values were statistically different.](fphar-11-00895-g002){#f2}

Next, equivalent recordings were performed from oocytes co-expressing Ci-VS-TPIP ([**Figure 2B**](#f2){ref-type="fig"}). Again, it was observed from the fit of the two-exponential function to the deactivating currents that both τ~1~ and τ~2~ also increased as a function of t~PULSE~ in these oocytes ([**Figures 2C, D**](#f2){ref-type="fig"}, red circles). However, both time constants tended to be smaller than those observed for the channel expressed alone only when the activation was prolonged. These findings indicated that the action of Ci-VS-TPIP has a stronger effect on K^+^-current deactivation when activation is prolonged. Accordingly, the difference between τ~1~ and τ~2~ from oocytes co-expressing the phosphatase and those expressing the channel along were greater as t~PULSE~ was longer, indicating that the effect of PI(4,5)P~2~ depletion was more prominent as activation persisted. In fact, τ~1~ values were significantly smaller only for t~PULSE~ was larger than 454 ms (*p* \< 0.01, *d.f.* = 21) ([**Figures 2C, G**](#f2){ref-type="fig"}). Likewise, τ~2~ values were significantly smaller than those in control oocytes for t~PULSE~ longer than 568 ms (*p* \< 0.05, *d.f.* = 21) ([**Figures 2D, H**](#f2){ref-type="fig"}).

The trend of the fraction of τ~2~ from oocytes co-expressing Ci-VS-TPIP was not significantly different than that from oocytes expressing the channels alone ([**Figures 2E, I**](#f2){ref-type="fig"}) (*p* \> 0.05, *d.f.* = 21). This indicated that the relative contribution of each component remained unaltered by the action of the phosphatase. Given these results, no clear pattern in the three kinetic parameters pointed at any specific mechanism underlying the decrease in the rate of deactivation. Therefore, as before, the kinetic parameters were consolidated into a single one. The calculated τ~DEACT~ from oocytes co-expressing Ci-VS-TPIP were significantly smaller only for t~PULSE~ longer than 186 ms (*p* \< 0.01, *d.f.* = 21) ([**Figures 2F, J**](#f2){ref-type="fig"}). This indicated that the effect of Ci-VS-TPIP was more prominent when activation was prolonged, suggesting the stabilization of the open channel was more sensitive to PI(4,5)P~2~ depletion.

Wortmannin Hinders the Decrease in the Deactivation Rate of the K~V~7.2/K~V~7.3 Channel {#s3_3}
---------------------------------------------------------------------------------------

One caveat to our interpretation above emerges from the fact that the effect of Ci-VS-TPIP may be due to the voltage- and time-dependence action of this phosphatase. Although the voltage-dependent activity of Ci-VS-TPIP can be observed at voltages as negative as −80 mV ([@B25]), it is possible that the lack of effect on the deactivation kinetics following short t~PULSE~ is due to low enzymatic activity of this phosphatases, so producing a modest PI(4,5)P~2~ depletion. To address this issue, an alternative approach to decrease PI(4,5)P~2~ in the membrane was employed, treating oocytes with the wide-spectrum phosphoinositide kinase inhibitor Wortmannin. This molecule is a furanosteroid isolated from the fungus *Talaromyces wortmannii* ([@B50]). Although it is a potent inhibitor of PI-3-kinase, Wortmannin also inhibits phosphoinositide 4-kinase at concentrations at the micromolar range ([@B49]). Because of this, Wortmannin has been shown to effectively decrease the concentration of PI(4,5)P~2~ in the plasma membrane ([@B65]; [@B99]; [@B29]; [@B4]; [@B5]; [@B56]; [@B20]; [@B71]; [@B33]).

Oocytes expressing K~V~7.2/K~V~7.3 channels were incubated in 10--20 µM Wortmannin for 30--60 min; the concentration of Wortmannin varied depending on the sensitivity to the treatment of each oocyte batch. As before, the H.P. was set at −90 mV, K^+^-currents were activated by applying 1,200-ms pulses with amplitudes ranging between −100 mV and +60 mV, and deactivation was driven at −105 mV ([**Figures 3A, B**](#f3){ref-type="fig"}). From these recordings, the amplitude of the deactivating ("tail") current was plotted against the amplitude of the activation pulse ([**Figure 3C**](#f3){ref-type="fig"}). From these plots it was found that the voltage-dependence for activation of the heteromeric K~V~7.2/K~V~7.3 was unaltered by the treatment with Wortmannin ([**Figure 3C**](#f3){ref-type="fig"}). However, as in the case of co-expressing Ci-VS-TPIP, deactivation of K^+^-currents in treated oocytes ([**Figure 3E**](#f3){ref-type="fig"}) was faster than that of untreated ones ([**Figure 3D**](#f3){ref-type="fig"}). These observations were consistent with the idea that channel deactivation was facilitated by reducing PI(4,5)P~2~ concentration.

![Effect of Wortmannin on the deactivation kinetics of K~V~7.2/K~V~7.3 channels. **(A, B)** *Xenopus* oocytes expressing K~V~7.2/K~V~7.3 channels were incubated for 30--60 min with 10--20 μM of the PI-kinase inhibitor Wortmannin to decrease the concentration of PI(4,5)P~2~. Compared with untreated oocytes (**A**, red arrow), K^+^-current deactivation was faster in oocytes treated with Wortmannin (**B**, red arrow). **(C)** Normalized I~TAIL~-V~PULSE~ shown no difference in voltage-dependence between untreated (*n* = 8) and treated oocytes (*n* = 13). **(D, E)** Examples of deactivating K^+^-currents from oocytes untreated **(D)** and treated **(E)** with Wortmannin. As on [**Figure 1**](#f1){ref-type="fig"}, deactivating K^+^-currents were fitted to a two-exponential function and the calculated τ~DEACT~ values were plotted against pulse potential (V~PULSE~, insets).](fphar-11-00895-g003){#f3}

To further evaluate the effect of Wortmannin, K^+^-currents were deactivated at −90 mV following activation by +40-mV pulses of variable duration ([**Figures 4A, B**](#f4){ref-type="fig"}). Fitting a two-exponential function to the deactivating currents yielded τ~1~ values that were significantly smaller than those from untreated oocytes when t~PULSE~ was longer than 200 ms (*p* \< 0.01, *d.f.* = 22) ([**Figures 4C, G**](#f4){ref-type="fig"}). In contrast, the values of τ~2~ were not significantly different between untreated and Wortmannin-treated oocytes ([**Figures 4D, H**](#f4){ref-type="fig"}). Yet, the fraction of τ~2~ obtained from recordings with Wortmannin-treated oocytes were significantly smaller with respect to those of untreated oocytes for t~PULSE~ longer than 200 ms (*p* \< 0.05, *d.f.* = 22) ([**Figures 4E, I**](#f4){ref-type="fig"}). This suggested that the overall slowdown of the deactivation was increasingly hindered by the action of Wortmannin as a function of t~PULSE~. To test this idea, τ~DEACT~ were calculated and plotted with respect to t~PULSE~ ([**Figure 4F**](#f4){ref-type="fig"}). As before, two phases were found: One initial phase with rapid increase of τ~DEACT~ with respect to t~PULSE~, and a second phase with a slower rate of increase of τ~DEACT~. The calculated τ~DEACT~ increased with t~PULSE~. However, these values were smaller for Wortmannin-treated oocytes with respect to those for untreated oocytes when t~PULSE~ was longer than 291 ms (*p \<* 0.01, *d.f.* = 22) ([**Figures 4F, J**](#f4){ref-type="fig"}). Overall, these observations were consistent with the finding that oocytes co-expressing Ci-VS-TPIP, showing that the slowdown of the deactivation kinetics of K~V~7.2/K~V~7.3 channels was impaired by either the action of the phosphatase or by the treatment with Wortmannin. Therefore, it is concluded that PI(4,5)P~2~ depletion has a higher impact on the deactivation rate following prolonged activation.

![Wortmannin treatment accelerates the deactivation kinetic of K~V~7.2/K~V~7.3 channels **(A)** As on [**Figure 2**](#f2){ref-type="fig"}, K^+^-current recorded from *Xenopus* oocytes expressing K~V~7.2/K~V~7.3 channels were activated with +40 mV pulses of variable duration and then deactivated at −90 mV. **(B)** Equivalent recordings were performed from oocytes treated incubated in 10 µM Wortmannin for 30--60 min. **(C, D)** The deactivating currents (red arrows in A, B) were fitted with a two-exponential function and τ~1~ and τ~2~ were plotted against the duration of the +40-mV activating pulse (t~PULSE~) for untreated (black open squares, *n* = 8) or Wortmannin-treated oocytes (red open circles, *n* = 14). **(E)** Relative contribution of the second component of the two-exponential function (fraction of τ~2~) *versus* t~PULSE~ for untreated (black open squares, *n* = 8) or treated oocytes (red open circles, *n* = 14). **(F)** Weighted average time constant (τ~DEACT~) plotted against t~PULSE~ untreated (black squares, *n* = 8) or treated oocytes (red circles, *n* = 14). **(G--J)** Semi-logarithmic version of the plot in **(C--F)**, detailing τ~DEACT~ for t~PULSE~ up to 1 s. Arrows in panel **(C, E--G, I, J)** indicate the range of t~PULSE~ values at which values were statistically different.](fphar-11-00895-g004){#f4}

PI(4,5)P~2~ Depletion Hampers the Activity-Dependent Stabilization of Open Channels by Retigabine {#s3_4}
-------------------------------------------------------------------------------------------------

It is known that depletion of PI(4,5)P~2~ alter the interaction of M-currents with drugs that promote their activity ([@B100]). Likewise, such drugs can partially compensate for the decrease in M-currents caused by PI(4,5)P~2~ depletion ([@B100]). Retigabine stabilizes the channels' open states as it increases the dwell time of open events ([@B73]; [@B69]). Consistently, Retigabine also decreases the deactivation rate of K~V~7.2/K~V~7.3 channels ([@B42]; [@B39]; [@B16]; [@B94]). Furthermore, at the micromolar range of concentrations (\<10 μM), Retigabine is more effective in decreasing the deactivation rate when K~V~7.2/K~V~7.3 channels have been long activated or when opened in steady state at typical neuronal resting potentials ([@B16]).

In the presence of 1 μM Retigabine, K~V~7.2/K~V~7.3 channels display up to a two-fold increase in their deactivation time constant when activated at +40 mV for at least 500 ms ([@B16]). However, activation with shorter pulses causes negligible changes in the deactivation rate ([@B16]). This indicates that the action of Retigabine at low concentrations on deactivation seems to require K~V~7.2/K~V~7.3 channels to be already activated and slowing down their deactivation rate. On the other hand, here it has been found that either co-expression of Ci-VS-TPIP or treatment with Wortmannin impairs the slowdown of the deactivation kinetics. This strongly suggests that PI(4,5)P~2~ depletion would hamper the further slowdown of the deactivation of K~V~7.2/K~V~7.3 channels induced by Retigabine. To test this hypothesis, once again K^+^-currents were recorded from oocytes co-expressing K~V~7.2/K~V~7.3 channels and the chimeric Ci-VS-TPIP ([**Figure 5A**](#f5){ref-type="fig"}). In the presence of 1 µM Retigabine ([**Figure 5B**](#f5){ref-type="fig"}), both τ~1~ and τ~2~ increased ([**Figures 5D, E**](#f5){ref-type="fig"}, blue open diamonds) and were larger than those fitted from recordings in the absence of the drug ([**Figures 5D, E**](#f5){ref-type="fig"}, red solid circles). However, the values of τ~1,~ τ~2~, and the fraction of τ~2~ were all smaller or equal than those observed in oocytes expressing the channels alone ([**Figures 5D, E, F**](#f5){ref-type="fig"}, black solid squares). This indicated that the stabilizing effect of Retigabine was mitigated by the action of the phosphatase. In order to see the slowdown of the deactivation induced by Retigabine, the concentration of the drug was increased to 5 µM ([**Figure 5C**](#f5){ref-type="fig"}). Under this condition, both τ~1~ and τ~2~ increases and were larger than those observed from oocytes expressing channels alone. With respect to oocytes co-expressing the phosphatase and in the presence of 1 µM Retigabine, both τ~1~ and τ~2~ were significantly larger for t~PULSE~ longer than 888 and 363 ms, respectively (both: *p* \< 0.01, *d.f.* = 11) ([**Figures 5D, E, G, H**](#f5){ref-type="fig"}, red open hexagons). The fraction of τ~2~ was also significantly higher for 5 µM with respect to 1 µM Retigabine when t~PULSE~ was 232 ms or larger (*p* \< 0.05, *d.f.* = 11) ([**Figures 5F, I**](#f5){ref-type="fig"}, red open hexagons). Overall, these observations indicated that PI(4,5)P~2~ depletion impaired the slowdown of the deactivation induced by Retigabine. To summarize these observations, τ~DEACT~-*vs*-t~PULSE~ plots were generated ([**Figure 6A**](#f6){ref-type="fig"}), showing τ~DEACT~ were significantly higher in the presence of 5 µM Retigabine with respect to 1 µM of the drug when t~PULSE~ were larger than 61 ms (*p* \< 0.01, *d.f.* = 11) ([**Figure 6B**](#f6){ref-type="fig"}). This reinforce the idea that PI(4,5)P~2~ depletion impairs the action of Retigabine, particularly when channels have been activated for longer periods of time.

![PI(4,5)P~2~ regulates the action of Retigabine. **(A--C)** K^+^-currents were activated with a +40 mV pulses of variable duration in *Xenopus* oocytes expression K~V~7.2/K~V~7.3 channels. Subsequently, the currents were deactivated at −90 mV. These recordings were performed in the absence **(A)** and the presence of 1 µM (blue diamonds, *n* = 6) and 5 µM of Retigabine (red triangles, *n* = 7) **(C)**. **(D--F)** A two-exponential function was fitted to deactivating currents and the yielded τ~1~, τ~2~ and the fractional contribution of the second component (fraction of τ~2~) were plotted against t~PULSE~. (**D--F**, respectively). **(G--I)** Semi-logarithmic version of the plot in **(D--F)**, detailing τ~DEACT~ for t~PULSE~ up to 1 second. For reference, the equivalent values from [**Figure 2**](#f2){ref-type="fig"} were plotted as small black square and small red circles. Black arrows in panels **(D--I)** indicate the range of t~PULSE~ values at which values were statistically different between the recordings in the presence of 1 µM and 5 µM Retigabine.](fphar-11-00895-g005){#f5}

![Overall deactivation kinetics as a function of the t~PULSE~. **(A)** As before, to consolidate the analysis of the deactivation kinetics, τ~DEACT~ was plotted against the duration of the +40-mV Pulse (t~PULSE~) for currents recorded in the presence of 1 μM and 5 μM Retigabine (blue open diamonds and red oepn hexagons, respectively). **(B)** The values of τ~DEACT~ were significantly different for t~PULSE~ longer than 61 ms. For reference, the equivalent values from [**Figure 2**](#f3){ref-type="fig"} were plotted as black solid square and red solid circles. **(C, D)** Equivalent τ~DEACT~-t~PULSE~ plots generated from Wortmannin-treated oocytes.](fphar-11-00895-g006){#f6}

To further test the idea that PI(4,5)P~2~ modulates the action of Retigabine, recordings were performed from oocytes expressing K~V~7.2/K~V~7.3 channels alone and treated with Wortmannin. In this case, a similar pattern emerged than with the co-expression of Ci-VS-TPIP. Although the slowdown the deactivation of the K~V~7.2/K~V~7.3 of Wortmannin-treated ([**Figures 6C, D**](#f6){ref-type="fig"}, red solid circles) was boosted by 1 µM Retigabine ([**Figures 6C, D**](#f6){ref-type="fig"}, blue open diamonds), it was not larger than that observed in untreated oocytes ([**Figures 6C, D**](#f6){ref-type="fig"}, black solid squares). Only increasing the concentration of Retigabine to 5 µM produced a significant slowdown in the deactivation kinetics ([**Figures 6C, D**](#f6){ref-type="fig"}, red open hexagons) larger than that in untreated oocytes ([**Figures 6C, D**](#f6){ref-type="fig"}, black solid squares). These combined observations indicated that the action of the Retigabine can be counteracted by either the action of Ci-VS-TPIP or the treatment with Wortmannin. This led to the conclusion that the action of Retigabine on the deactivation kinetics is strongly modulated by PI(4,5)P~2~, particularly following prolonged activation.

Discussion {#s4}
==========

Here, it has been shown that either the co-expression of Ci-VS-TPIP or the treatment with Wortmannin had an unambiguous effect on the kinetics of deactivation when it followed prolonged activation. Consistent with previous reports, it seems that K~V~7.2/K~V~7.3 channels undergo a process of stabilization of their activated/open conformation when they are activated for prolonged periods of time. In addition, this underlying process for stabilization seems to require PI(4,5)P~2~. This is consistent with a study showing that K~V~7.2 expressed in CHO cells show a unambiguous decrease in the deactivation rate when co-expressed with the phosphoinositide kinase PI5K, indicating that increasing the concentration of PI(4,5)P~2~ slowdown deactivation ([@B14]). Yet, it has been shown no change in the deactivation kinetics of M-currents upon application of Muscarine in trypsin-digested isolated bullfrog lumbar sympathetic ganglia ([@B2]). It is not clear what the reason for this discrepancy is. However, it is to be considered that other factors are in play when studying M-currents in a native system. For instance, in neurons for a sympathetic ganglion, Muscarine activate muscarinic GqPCRs that degrades PI(4,5)P~2~ into DAG and IP~3~, so increasing the concentration of Ca^2+^ through IP~3~ receptors. As Ca^2+^ is known to modulate M-currents, decreasing their deactivation rate ([@B95]), it is possible that the apparent discrepancy mentioned here arises from a combination of factor playing in the native system.

Another aspect to be considered is the potential effect of PI(4)P when produced by Ci-VS-TPIP after dephosphorylating PI(4,5)P~2~. Although the experiments reported here cannot tell what the effect of PI(4)P would be on the activity of K~V~7.2/K~V~7.3 channels, previous reports have shown that the conversion of PI(4,5)P~2~ into PI(4)P by Ci-VSP and Dr-VSP render the channels inactive ([@B47]; [@B80]; [@B34]). So, in principle, it is unproven, yet reasonable to assume that PI(4)P is ineffective in sustaining the activity of K~V~7.2/K~V~7.3 channels. Consistently, it has been shown that the PI(4)P-analog diC~8~PI(4)P is has a lower potency than the PI(4,5)P~2~-analog diC8PI(4,5)P~2~ to sustain M-current activity ([@B75]).

An additional consideration is related to the ability of oocytes to either regenerate or maintain PI(4,5)P~2~ levels. To this, it is important to consider that the current implementation of the COVC technique relies on making a chemical "perforation" in a restricted and small area of the oocyte's plasma membrane using a mild detergent treatment (Saponin, 0.1% in intracellular recording solution). Thus, the oocytes conserved its integrity. Even when expressing VSPs in oocytes, PI(4,5)P~2~ can be degraded by over and over again as the oocyte regenerates as evidenced by the recovery of the current as VSP deactivation ([@B80]; [@B25]).

A final consideration on the use of VSPs is the potential effect that they can have on channel activity their enzymatic properties. It has been shown that the inactivated chimeric Ci-VS-TPIP-C363S affects the activation of K~V~7.4 channels expressed in Chinese Hamster Ovary (CHO) cells ([@B25]). This suggests that it is possible that there is interaction between these proteins. Although this issue was not directly addressed in the present study, the activation of K~V~7 channels in oocytes co-expressing Ci-VS-TPIP did not display any obvious differences with respect to the activation in oocytes expressing the channels alone. Example of that can be seen in [**Figure 1**](#f1){ref-type="fig"}.

Modal Behavior {#s4_1}
--------------

The work presented here reinforces the idea that this heteromeric channel displays at least two modes of activity once activated. A first mode that is reached immediately upon activation and a second mode that is reached once activation has been prolonged. Further, the second mode of activity seems to be more stable than the first one because deactivation is slower from it. Furthermore, it was shown that PI(4,5)P~2~ depletion has a relative stronger effect on deactivation as channels are activated for longer periods of time. This suggests that K~V~7.2/K~V~7.3 channels in their second mode of activity are more sensitive to PI(4,5)P~2~ depletion.

Modal gating has been documented in the activity of many types of channels and it has been shown to be critically involved in their function ([@B52]; [@B44]; [@B51]; [@B97]; [@B98]; [@B41]; [@B72]; [@B12]; [@B7]). To understand modal gating, it is essential to define what a "mode" is. In theory, a "mode" constitutes a cluster of interconnected states (typically open and closed) in which a channel dwells for a certain period of time until it transitions to a state belonging to another cluster ([@B22]). A mode can be seen as "bursts" or "trains" of repetitive opening and closing events. These bursts share similar open probability and lifetimes of open and close channel events. So, a channel can sojourn in one mode and eventually transition into a different mode, changing their open probability and/or events' lifetime.

One well-documented case of modal gating is the one observed in the activity of the Ryanodine Receptor type 2 (RyR2) ([@B24]; [@B97]; [@B98]; [@B22]). These Ca^2+^-activated channels have at least two modes of open channel activity which are known as the high open probability (HPo) and the low open probability (LPo) modes. Interestingly, RyR2 generally opens into their HPo mode when activated by a rapid increase in Ca^2+^ concentration ([@B24]). Then, RyR2 starts reversibly sojourning between modes. When reaching a steady state, HPo and LPo modes are both populated in a Ca^2+^-dependent manner, effectively decreasing the overall open probability ([@B24]; [@B97]; [@B98]; [@B22]). Because the HPo mode is first reached, the activity of RyR2 is always higher immediately after activation with respect to steady state ([@B98]; [@B22]). This is the basis for what is known as "RyR adaptation" which is critical for the control of Ca^2+^-induced Ca^2+^ Release in cardiac myocytes ([@B24]; [@B98]).

Modal gating is also observed in the activity of the bacterial potassium-selective channel KcsA. This channel displays three modes, namely, High Po, Low Po, and Flickering modes ([@B12]). Interestingly, mutation of the residue E71 in the selectivity filter of KcsA can strongly modulate the likelihood of observing these modes and their kinetics ([@B12]). Modal gating is the underlying process of slow inactivation in the activity of KcsA.

For RyR2, KcsA, and some neuronal receptors such acetylcholine and NMDA receptors that undergo desensitization ([@B52]; [@B41]; [@B7]), modal gating is correlated with the decrease of channel activity as activation is prolonged. However, this is not the case in K~V~7 channels. Modal activity in the heteromeric K~V~7.2/K~V~7.3 channels seems to increase or stabilize their activity as deactivation becomes slower as activation persists.

Modal Behavior and K~V~7 Pharmacology {#s4_2}
-------------------------------------

The idea of modal gating in the activity of K~V~7 channels was first introduced by N.V. Marrion in 1993, and other subsequently ([@B44]; [@B60]). At the single channel level, it has been found that M-currents can display two types of "activity bursts" that where distinguished by their open probability and the lifetime of their open channel events. This observation showed for the first time that K~V~7 channels can operate in more than one mode.

It has been shown from single channel recordings of M-currents that the frequency of longer-living open channel events decreases upon the application of Muscarine ([@B44]). This indicates that modal gating is modulated by PI(4,5)P~2~. Consistently, we observed here that the slowdown of the deactivation is impaired following PI(4,5)P~2~ depletion. This strongly suggest that the modal behavior can be targeted by PI(4,5)P~2~ regulation.

The slowdown of the deactivation is here referred to in terms of "modal behavior" or "modal activity". These terms have been intentionally used to make a distinction with the concept of "modal gating". This is because single channel analysis escapes the scope of the present study and is yet-to-be correlated with the change in the deactivation kinetics. Nonetheless, the fact that deactivation becomes slower strongly suggests a modal transition in the activity of these channels as activation is sustained. Supporting the idea of modal activity in K~V~7.2/K~V~7.3 channel is the observation that Retigabine has a stronger impact on deactivation as they are kept activated. Furthermore, this study has shown that PI(4,5)P~2~ depletion also displays a differential effect, having a higher impact on deactivation after prolonged activation. These kinetic, pharmacological, and regulatory types of evidence strongly support the notion of modal activity in K~V~7.2/K~V~7.3 channels.

PI(4,5)P~2~ and K~V~7 Modal Behavior {#s4_3}
------------------------------------

The molecular basis for the apparent differential modal sensitivity of the deactivation rate to PI(4,5)P~2~ depletion is yet-to-be defined. However, there are at least two alternatives worth discussing. One is that, since the homomeric K~V~7.2 and K~V~7.3 channels have distinct affinities for PI(4,5)P~2~ ([@B18]; [@B74]), it is possible that the differential modal sensitivity to PI(4,5)P~2~ depletion emerges from the distinct affinities of the subunits. If this was the mechanism, it would imply that the action of PI(4,5)P~2~ in activation and stabilization of the open conformation of the channels would depend on the subunit that this lipid is bound to. An alternative option is based on the existence of multiple binding sites for the PI(4,5)P~2~ within each subunit of the K~V~7.2/K~V~7.3 channel ([@B99]; [@B40]; [@B27]; [@B28]; [@B77]; [@B75]; [@B76]; [@B14]). In this case, the role of PI(4,5)P~2~ in the processes of activated/open channel stabilization will depend on which binding site is bound to. In this case, the affinity to the binding involved in stabilization would be lower than other sites as stabilization was shown to be more sensitive to PI(4,5)P~2~ depletion. The idea that distinct binding sites have different roles in activation and deactivation is consistent with a previous report suggesting PI(4,5)P~2~ switches position during activation, migrating from the S2-S3 linker to the S4-S5 linker ([@B14]).

The first putative mechanism implies that inter-subunit differences in affinity are responsible for the increased sensitivity to PI(4,5)P~2~ depletion. The second mechanism implies that multiple sites within each subunit play distinct role in activation and stabilization. Although the approach taken in this study does not allow discriminating between the first inter-subunit and the second intra-subunit multiple-site models, one important distinction between the two models is that the first one would predict that homomeric channels may not display modal behavior. To provide an initial approximation to addressing this issue, K^+^-currents were recorded from *Xenopus* oocytes expressing the homomeric K~V~7.2 channel. As for the heteromeric channel, the H.P. was set at −90 mV, channels activated by 1,200-ms pulses ranging from −100 to +60 mV, and then deactivated at −105 mV ([**Figure 7**](#f7){ref-type="fig"}). As expected, deactivation of the K^+^-currents was slowed down by Retigabine ([**Figures 7A, B**](#f7){ref-type="fig"}, red arrow). At this low concentration of RTG, under the conditions the recordings were made, a negligible shift in the K~V~7.2 channel's voltage-dependence of activation was observed toward negative potential. Next, the effect of activation on deactivation was evaluated by activating the channels with +40-mV pulse of variable duration, following with deactivation at −90 mV ([**Figure 8A**](#f8){ref-type="fig"}). As before, τ~DEACT~ values were calculated and plotted against the duration of the activating pulse (t~PULSE~) ([**Figure 8C**](#f8){ref-type="fig"}, black open squares). Like for the heteromeric K~V~7.2/K~V~7.3 channel, τ~DEACT~-t~PULSE~ curves exhibited two clear phases in the slowdown of the deactivation of the homomeric K~V~7.2 ([**Figure 8C**](#f8){ref-type="fig"}, black open squares). Addition of 10 µM Retigabine induced an increase in the time constant of deactivation ([**Figure 8B**](#f8){ref-type="fig"}). As before, τ~DEACT~ for short activation pulses (\<36 ms) were unaffected by 10 µM Retigabine (*p* \< 0.01, *d.f.* = 15) ([**Figures 8C, D**](#f8){ref-type="fig"}, red open circles). These observations led to conclude that the homomeric K~V~7.2 channel also displays at least two modes of activity, implying that modal behavior is intrinsic of each subunit---or at least of the K~V~7.2 subunit---and not arise from it being a heteromeric protein.

![K^+^-currents from oocytes expressing K~V~7.2 channels, before **(A)** and after adding 10 μM RTG **(B)**. The current deactivation slowed down in the presence of the drug (red arrows). **(C)** Deactivation current amplitude (I~TAIL~) were normalized respect the largest current amplitude (I~TAIL,MAX~). The average of the normalized currents were plotted versus the activating voltage (*n* = 15).](fphar-11-00895-g007){#f7}

![To determine whether the decrease in the rate of deactivation was a unique property of the heteromeric K~V~7.2/K~V~7.3 channel. **(A, B)** K^+^-current recordings from oocytes expressing K~V~7.2 in the absence and presence of 10μM Retigabine (RTG). **(C)** τ~DEACT~ was plotted as a function of t~PULSE~ for the homomeric K~V~7.2. It was found that the slow down of the deactvation kinetics still occurs when K~V~7.2 was expressed alone, suggesting that the hysteretic behavior of these K~V~7 channels was not a property emerging from heteromerization (*n* = 5). **(D)** τ~DEACT~-t~PULSE~ plots in C, replotted with a logarithmic t~PULSE~ to highlight the behavior of τ~DEACT~ at short t~PULSE~ values.](fphar-11-00895-g008){#f8}

Molecular Basis for Modal Behavior in K~V~7 Channels {#s4_4}
----------------------------------------------------

Consistent with previous studies ([@B39]; [@B32]), results from in the present study show that Retigabine was able to overcome the effect of the partial depletion of PI(4,5)P~2~ in the activity of K~V~7.2/K~V~7.3 channels. In addition to this observation, a novel finding was that both the effect of Retigabine and the effect of PI(4,5)P~2~ depletion are more prominent following prolonged activation. This led to the conclusion that the modal behavior of K~V~7.2/K~V~7.3 channels is modulated by both Retigabine and PI(4,5)P~2~.

Retigabine binds to the channel's pore, implying that that its effect is likely mediated by this domain. Thus, one emerging question is: what is the mechanism for mode switching? It has been proposed that both the VSD and the pore of channels can display hysteretic behavior ([@B84]). Hysteresis is a property of physical and chemical systems in which the response of such system to an external force or field depends on the current status of the systems. In general, channels are thought to have a defined voltage-dependence. However, a growing body of evidence shows that voltage dependence is dynamic an dependent on activity itself ([@B84]). The response to changes in the membrane potential has been shown to be activity-dependent in channels such as *Shaker (*[@B37]*)*, HCN ([@B43]; [@B21]; [@B11]; [@B93]), K~V~3.1 ([@B36]), Na~V~ ([@B6]), and KcsA ([@B78]), among others. For voltage-gated channels, hysteresis typically manifests as a shift in voltage-dependence toward negative potentials, a decrease in the deactivation rate, or both ([@B16]). This implies that activation and deactivation follow distinct pathways or sequence of events. In the case of K~V~7.2/K~V~7.3, deactivation is initially fast, slowing down as the channels remain activated. This indicates that a transition to a more stable open mode of activity occurs as activation persists, implying that deactivation follows a distinct path toward resting states.

A minimal voltage-gated channel is composed of a pore domain and four voltage-sensing domains. So, the question is, which of these domains may cause modal or hysteretic behavior in a channel? Although this question is yet to be answered, there is evidence suggesting that action of both domains can drive these behaviors. For instance, a recent study shows that the bacterial K^+^-channel KcsA can display hysteresis in its activation. This hysteretic behavior is manifested as a shift in their pH dependence for activation ([@B78]). This means that the affinity for hydrogen ions depends on whether the channel is activated or deactivated ([@B78]). This study suggests, therefore, that an "isolated" pore can exhibit hysteresis. On the other hand, the voltage-dependence for sensing charge movement of an "isolated" VSD can change as a function of activity, shifting to more negative potential following activation ([@B79]) and/or making deactivation slower ([@B35]). At this point, it cannot be established if any of these fundamental mechanisms---or any other---is ultimately responsible for modal behavior or hysteresis in the activation of K~V~7.2/K~V~7.3 channels. However, changes in the deactivation rate induced in this study with enzymatic and pharmacological means show a more prominent effect of deactivation, virtually sparing voltage-dependence. This suggests that conformational rearrangements in the pore domain might be a key factor in the modal behavior of K~V~7 channels.

Here, it was shown that there is a link between the regulation by PI(4,5)P~2~ and modal behavior of the K~V~7.2/K~V~7.3 channel. This suggests that GqPCR-mediated modulation may target K~V~7 channel modal behavior. Since the action of Retigabine was also strongly dependent on modal activity, it can be concluded that GqPCR activity is likely an important modulator of K~V~7 channel's pharmacology.

Retigabine-Induced Shift in Voltage Dependence {#s4_5}
----------------------------------------------

Except for K~V~7.1 channels, it has been commonly reported that retigabine induces a shift in the voltage-dependence for activation of K~V~7 channels, facilitating opening. Under the experimental conditions used in the present study, low concentrations of retigabine (≤10 µM) were able to induce shifts in the voltage dependence for activation of K~V~7.2 and K~V~7.2/K~V~7.3 channels that were smaller than those reported elsewhere. There is not clear explanation for such discrepancy. Yet, there are some considerations that may help explaining it. First, most of the papers reporting the effect of retigabine on K~V~7 channels expressed in oocytes have used the Two-Electrode Voltage-Clamp (TEVC) technique. Employing this technique, we observed in my lab similar shifts in the conductance-*vs*-voltage (G-V) curves of K~V~7.2/K~V~7.3 channels that resembled those reported in the literature. We also observed a large variability in the magnitude of the shift. Furthermore, we noted that the washout of the drug allowed the return of the G-V curve to more positive voltages, but deactivation remained slower. This led us to hypothesize that the variability observed was due to limitation of the TEVC technique ([@B3]) which was likely exacerbated by the slow deactivation kinetic of the channels. So, it was then decided to change our approach and employ the COVC technique because it offers better space and temporal control of the membrane potential ([@B70]; [@B64]). Regretfully, we did not perform further investigation of the issue.

Another important consideration is that the slow kinetic of K~V~7 channels constitutes a challenge in itself when studying slow transition in channel behavior. In this and in our previous study ([@B16]), 1 µM of retigabine increased the average deactivation time constant of K~V~7.2/K~V~7.3 channels to approximately 600 ms at −90 mV when following an activating +40-mV pulse of 2 s in duration. This was almost twice the time needed for the channels to close in the absence of the drug. Assuming an exponential deactivation process, a 600-ms time constants means that 3 s was the minimum time required to reach 99% of channel closure. Further, 5 µM of retigabine caused an additional doubling of the deactivation time ([@B16]), implying the need of 6 s to allow channels to close. Furthermore, these estimated deactivating times may be even longer if considering that channel closure does not imply full deactivation, as deactivation also involves transition through closed states ([@B96]). Some published studies have used protocols with H.P.s at −80 mV and deactivating potentials at −30/−40 mV. We have observed deactivation time constants of up to 2.5 s at −80 mV in the presence of 1 µM retigabine ([@B16]). This indicates that closure could take at least 12 s at such potentials. Being very cognizant of this notion, recordings were performed for the present study providing long periods of time to allow channels to fully deactivate. For instance, 10 s or more for channels to deactivate at −105 mV ([**Figures 1**](#f1){ref-type="fig"}, [**3**](#f3){ref-type="fig"}, and [**7**](#f7){ref-type="fig"}) and at least 16 s when deactivating at −90 mV ([**Figures 2**](#f2){ref-type="fig"}, [**4**](#f4){ref-type="fig"}, [**5**](#f5){ref-type="fig"}, and [**8**](#f8){ref-type="fig"}). It is noteworthy that this is not uncommon feature of channels held active for a long time. For instance, channels like *Shaker*, which is "very fast channels", can take seconds to fully deactivate ([@B37]). Therefore, we speculate that the source of discrepancy between this and other studies may emerge from differences in the pulse protocols used. Deactivation time constants and periods of recovery are to be carefully designed during electrophysiological studies using voltage-clamp techniques.

Modeling the Activity of K~V~7.2 Channels {#s4_6}
-----------------------------------------

Five models for the activity of K~V~7.2 were evaluated ([**Figure 9A**](#f9){ref-type="fig"}). Models "00" and "0" cannot display modal behavior as they are based on unbranched, sequential kinetic schemes. Models A, B, and C may display modal behavior depending on the rates. Transition in the horizonal direction have rates names α and β which were considered to be functions of the voltage. Transitions in the vertical direction have rates named γ and δ which were considered voltage-independent for simplicity.

![**(A)** Kinetic models considered to describe the activity of K~V~7.2 channels. **(B)** Example of fitted currents data (red traces) overlapping experimentally recorded current traces (black traces). Details in the text. **(C)** Square difference (SD) between the fitted and recorded traces. SD = ∑(I~RECORDED~-I~FITTED~)^2^.](fphar-11-00895-g009){#f9}

Using a framework for analysis previously developed ([@B83]), each model was simultaneously fitted to activating and deactivating currents recorded from an oocyte expressing K~V~7.2 channels ([**Figure 9B**](#f9){ref-type="fig"}). Activation was driven from a H.P. of −90 mV by voltage pulses with amplitudes ranging from −50 to +40 mV. The deactivation was driven at −90 mV, following +40-mV pulses of increasing duration, ranging from 48 to 4,235 ms. The quality of the fit was assessed by calculating the square difference (SD) between the recording and the fitted traces. For each model, five trials with randomly seeded parameters were used to initialize the fitting. Then, five trials were seeded with the average parameters obtained from the initialization step and let run to obtain the final fitted parameters. The fitted models shown here are part of an ongoing study. In this phase of that study, model B has been the best fitted model according to calculated SD values ([**Figure 9C**](#f9){ref-type="fig"}). This is likely due to the larger number of parameters in model C which requires larger number of iterations.

The fitted parameters for model B showed that the rates between states C~0~ through C~4~ are strongly voltage dependent ([**Figure 10B**](#f10){ref-type="fig"}). Accordingly, about 1.6 electron-charges per subunit are associated to these transitions, accounting for 96% of the total sensing charges of the model. On the other hand, transitions between states C~4~, O~1~, and O~2~ display low voltage-dependence, accounting for the remaining 4% of sensing charges. Another important finding is that the transition rates γ~C4~, δ~C4~, γ~O1~, and δ~O1~ were at least one order of magnitude smaller than γ~C3~, δ~C3~, γ~O2~, and δ~O2~ ([**Figure 10A**](#f10){ref-type="fig"}). This made the transitions between C~4~ and C~4s~ and between O~1~ and O~1s~ very unlikely. In addition, given the value of z~α1~ and the transition coefficient α~1~, the rate of transition from C~3~ to C~4~ at +40 mV would be three times larger than γ~C3~ which is the transition rate from C~3~ to C~3s~. Further, α~O1~ was more than three times α~1s~, implying that the transition from C~4~ to O~1~ would readily "drain" the state C~4~, effectively increasing the transition rate from C~3~ to C~4~. Furthermore, γ~O2~ was higher than δ~O2~. This led to conclude that there is a preferred direction in the model, having state O~2~ being populated first following activation and with state O~2s~ being populated as the activation is prolonged. It is important to note that the preferred direction does not violate the micro-reversibility principle. In fact, micro-reversibility was checked at every step of the fit (between 50,000 and 150,000 iterations per trial). From this preliminary study, model B was simplified into an "interpreted" (or effective) model B ([**Figure 10C**](#f10){ref-type="fig"}). The interpreted model B is consistent with the existence of two modes in the activity of K~V~7.2 channels.

![Fitted parameters for model B. **(A)** Rate coefficients for transitions. **(B)** Elementary charges associated to the transtion. **(C)** Simplification of the model B based on the rates. Blue arrows indicate preferred direction immediately after activation (green arrow) and during deactivation following prolonged activation botton (red arrow).](fphar-11-00895-g010){#f10}

A Final Thought on the Use of a Two-Exponential Function for Quantifying Changes in the Deactivation Kinetics {#s4_7}
-------------------------------------------------------------------------------------------------------------

As in previous studies on the activity of K~V~7 and other K~V~ channels ([@B89]; [@B35]; [@B55]; [@B36]; [@B16]), this function was chosen because it is able to tightly trace the deactivation of the K^+^-currents studied here. It is important to stress that the use of a two-exponential function does not mean that the model has two states or modes or ways to be activated or deactivated. This is a misconception that is commonly adopted. Strictly speaking, the number of components in a function describing the behavior of a channel will be equal to the total number of kinetics states ([@B83]). Thus, if a channel has one closed and two open states, then the number of components should be three. I believe that it is unarguable that channels like those of the K~V~ family have multiple states---say, at least five closed (given that they have four VSDs) and one open ([@B96]). This means that the minimum number of components should be 6, with one of the exponents being zero. When fitting the kinetics of deactivation, this will involve fitting 10 kinetic parameters, namely, time constant and amplitude of each component, plus the baseline (which is the pre-exponential value of the zero-exponent term) ([@B96]; [@B83]). This argument should suffice to make the point that, beyond the simple temporal description of the deactivation, interpreting the four kinetic parameters yielded by fitting the data to a two-exponential function is inadequate as it contains insufficient information. Furthermore, this is also the reason why assigning physical meaning to these parameters can be misleading and/or inadequate.
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